How the Rich Are Buying Genetically Upgraded Babies
Breakthroughs in CRISPR and human germline editing aremoving genetic engineering from curing rare diseases to rewriting the inheritedDNA of future generations. In this investigative documentary, we examine themulti-billion-dollar race to commercialize human genetics—and ask what happenswhen biological upgrades are locked behind a corporate paywall.
As bioethics committees slowly reconsider bans on heritable germlineediting, the boundary between curing fatal disease and commercial traitenhancement is beginning to blur. When polygenic embryo selection merges withmulti-million-dollar medicine…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.